Mettler-Toledo Advises How to Avoid Out-of-Specification (OOS) Results

News   Mar 17, 2014

 
Mettler-Toledo Advises How to Avoid Out-of-Specification (OOS) Results
 
 
 

RELATED ARTICLES

PhoreMost and Plexxikon Collaborate to Identify Novel Drug Targets

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.

READ MORE

‘Coffee Filter’ Makes Production of Cancer Drug Much Cheaper

News

Making drugs cheaper doesn't always require pricey investments. What started out as a Bachelor project at TU/e laid the foundation for a much cheaper production of the promising cancer drug Z-endoxifen.

READ MORE

Worms Exhibit Fear and Respond to Anti-anxiety Meds

News

A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE